The routine accination for one type of meningococcus bacteria, Type C, was introduced Australia-wide in 2003, costing $41 million in its first year.

• 针对脑炎球菌一个型，即C型的传统疫苗，已经于2003开始在澳大利亚境内试用，第一年耗费了41，000，000美圆。